As of 2024-12-14, the Intrinsic Value of Humanigen Inc (HGEN) is
-406.46 USD. This HGEN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.04 USD, the upside of Humanigen Inc is
-1,126,023.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-406.46 USD
Intrinsic Value
HGEN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(941.96) - (313.21) |
(450.68) |
-1248512.8% |
| DCF (Growth 10y) |
(327.49) - (912.06) |
(456.32) |
-1264141.0% |
| DCF (EBITDA 5y) |
(329.19) - (403.37) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(340.43) - (432.80) |
(1,234.50) |
-123450.0% |
| Fair Value |
-406.46 - -406.46 |
-406.46 |
-1,126,023.80% |
| P/E |
(2,240.40) - (2,477.77) |
(2,186.75) |
-6057569.7% |
| EV/EBITDA |
(1,172.45) - (1,328.37) |
(1,219.23) |
-3377455.5% |
| EPV |
(1,663.53) - (2,182.52) |
(1,923.02) |
-5327023.0% |
| DDM - Stable |
(625.06) - (2,468.98) |
(1,547.01) |
-4285454.3% |
| DDM - Multi |
(124.58) - (401.09) |
(192.32) |
-532842.7% |
HGEN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.02 |
| Beta |
-4.25 |
| Outstanding shares (mil) |
0.66 |
| Enterprise Value (mil) |
-3.08 |
| Market risk premium |
5.00% |
| Cost of Equity |
10.03% |
| Cost of Debt |
7.00% |
| WACC |
7.59% |